Chondrolysis: Shoulder pain pumps may increase risk of injury. Our lawyers investigate
Did you develop shoulder chondrolysis after receiving a shoulder pain pump? Discuss your situation with our lawyers
The Food and Drug Administration (FDA) has reviewed 35 reports of shoulder chondrolysis (necrosis and destruction of cartilage) in patients given continuous intra-articular infusions of local anesthetics (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine and ropivacaine) with elastomeric infusion devices to control post-surgical pain.
The significance of this injury to otherwise healthy young adults warrants notification to health care professionals.
Read the complete FDA release
The local anesthetics (with and without epinephrine) were infused for extended periods of time (48 to 72 hours) directly into the intra-articular space using an elastomeric pump.
Shoulder chondrolysis was diagnosed within a median of 8.5 months after the infusion.
Almost all of the reported cases of chondrolysis (97%) occurred following shoulder surgeries.
Joint pain, stiffness, and loss of motion were reported as early as the second month after receiving the infusion.
In more than half of these reports, the patients required additional surgery, including arthroscopy or arthroplasty (joint replacement).
A representative of our firm will be in touch shortly.
Pump Anesthetics Shoulder Pain Pump Anesthetics | Weitz & Luxenberg
Did you sustain further shoulder damage after surgery? Legal options
FDA FDA Report Shoulder Chondrolysis Pain Pump | Weitz & Luxenberg
Did you develop chondrolysis after shoulder surgery? Free legal review
Shoulder Pain Pumps Pain pumps now known to cause serious damage to the joints: Weitz & Luxenberg can help
Were your joints permanently damaged by pain pumps? Trust Weitz & Luxenberg with your case.